- Wall Street sees new obesity pills as priced near Wegovy and Zepbound Reuters
- Retatrutide: The newest weight loss drug showing promise KTBS 3
- Eli Lilly (LLY) Announced Positive Results From its Phase 3 ATTAIN-1 Trial of Orforglipron Yahoo Finance
- Most things driving people to sell don’t get undone quickly, says Jim Cramer MSN
- Orforglipron Reduces Body Weight in Adults With Obesity Endocrinology Advisor